Socio-Cultural Dimensions of Emerging Infectious Diseases in Africa: An Indigenous Response to Deadly Epidemics
暫譯: 非洲新興傳染病的社會文化面向:對致命疫情的本土回應

Tangwa, Godfrey B., Abayomi, Akin, Ujewe, Samuel J.

  • 出版商: Springer
  • 出版日期: 2019-08-30
  • 售價: $5,230
  • 貴賓價: 9.5$4,969
  • 語言: 英文
  • 頁數: 297
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3030174735
  • ISBN-13: 9783030174736
  • 海外代購書籍(需單獨結帳)

商品描述

This volume examines the most important socio-cultural, political, economic, and policy issues related to emerging infectious diseases in Africa. The volume covers the work of the Global Emerging Pathogens Treatment Consortium (GET); it looks at the challenges of science education and communication in Africa, the global health and governance of pandemics and epidemics, and more. It looks beyond such threats as Ebola, SARS, and Zika to consider the ways communities have sought to contain these and other deadly pathogens. The chapters provide a better understanding of a global health problem from an African perspective, which help clarify to readers why some responses have worked while others have not.

 

Overall, the volume captures the state of the art, science, preparedness, and evolution of a topic important to the health of Africa and the world. It has a broad appeal across disciplines, from medical science and biomedical research, through research ethics, regulation and governance, science and health communication, social sciences, and is also of interest to general readers.

 

商品描述(中文翻譯)

本卷探討與非洲新興傳染病相關的最重要社會文化、政治、經濟和政策議題。該卷涵蓋了全球新興病原體治療聯盟(Global Emerging Pathogens Treatment Consortium, GET)的工作;它考察了非洲科學教育和溝通的挑戰、全球健康以及疫情和流行病的治理等問題。它超越了埃博拉、SARS 和茲卡等威脅,考慮社區如何努力控制這些及其他致命病原體的方式。各章節提供了從非洲視角更好地理解全球健康問題的機會,幫助讀者釐清為何某些應對措施有效而其他則無效。

總體而言,本卷捕捉了與非洲及全球健康相關的重要主題的最新狀態、科學、準備和演變。它在醫學科學、生物醫學研究、研究倫理、法規與治理、科學與健康溝通、社會科學等多個學科中具有廣泛的吸引力,對一般讀者也有興趣。

作者簡介

Godfrey Tangwa: Godfrey B. Tangwa is emeritus professor of the University of Yaounde 1, Cameroon, where he was Head of the Department of Philosophy from 2004-2009. He is a Fellow of the Cameroon Academy of Sciences (CAS), the African Academy of Sciences (AAS), Vice Chairperson of the Cameroon Bioethics Initiative (CAMBIN) which he founded in 2005, an executive committee member of the Pan-African Bioethics Initiative (PABIN) and Chairperson of the Cultural, Anthropological, Social and Economic (CASE) work group of the Global Emerging Pathogens Treatment Consortium (GET). He has extensive teaching and research experience in the domains of philosophy and bioethics. He obtained a BA (1977) from the University of Nigeria, Nsukka, an MA (1979) from the University of Ife (now Obafemi Awolowo University), Ile Ife, and a PhD (1984) from the University of Ibadan, all in Nigeria. He has served on several expert advisory committees for the WHO, has been a member of the Scientific Ethics Advisory Group (SEAG) of Hoffmann La Roche since 2005 and is currently also an advisory board member of both ALERRT and SARETI. Professor Tangwa's publications' record shows about 10 books, 35 book chapters and 45 journal articles.

 

Akin Abayomi is Professor of Medicine at the Nigerian Institute of Medical Research in Lagos, Nigeria. Prior to that he was the Chief Pathologist and Head of the Division of Haematology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. A specialist in internal medicine and haematology, environmental health and biosecurity, Professor Abayomi studied at the Royal Medical College of St Bartholomew's Hospital in the University of London where he attained his first graduate degree in medicine. He has obtained fellowships from the Royal College of Medicine and Pathology in the United Kingdom and the College of Medicine of South Africa. He has worked in several countries around the world in both internal medicine and haematology and has been exposed to a variety of geographical variations and disease patterns within these areas. Professor Abayomi's focus has mainly been on the concept of emerging diseases like Ebola, HIV and TB and the development of laboratory and clinical capacity in Africa. He is the cofounder and Principal Investigator of the Global Emerging Pathogens Treatment Consortium (GET).

Samuel Ujewe is a scholar, researcher and analyst in Bioethics & Health Policy, especially: health research ethics, healthcare ethics, mental health ethics, indigenous populations' health ethics & policy, global health ethics & policy, ethics of infectious diseases management, international and cross-cultural bioethics. His research interests span through integrating major ethical theories with relevant indigenous principles and values to enhance just, responsible and actionable health policies and interventions, especially in African health systems.His research focuses on the intersection of ethics and policy, using a moral compass that aligns with indigenous contexts. He obtained a PhD in Bioethics & Health Policy from the University of Central Lancashire, United Kingdom; a Master of Health Sciences (MHealSc) in Bioethics from the University of Otago, New Zealand; and a First Class BA Hons in Philosophy from the University of Zimbabwe. He has since completed two postdoctoral fellowships at the University of Pretoria, South Africa, and McMaster University, Canada. He is currently an Adjunct Research Fellow at the Canadian Institute for Genomics and Society, where he undertakes collaborative research on the ethical implications of genomic innovations for indigenous settings.

Dr Ujewe is an Associate Fellow of the Higher Education Academy, UK; a member of the International Forum of Teachers of Ethics, Bioethics and Medical Law (IFT); and a Fellow of the Global Emerging Pathogens Treatment Consortium (GET), working with the "Cultural, Anthropological, Social, and Economic Impact (CASE) Work Group". He has also held Visiting Research Fellowshipsat the University of Central Lancashire in Cyprus, and The Nathaniel Center, New Zealand.

 

Nchangwi Syntia Munung is based at the University of Cape Town (UCT), South Africa. She holds an M.Sc in Biochemistry and an M.Sc in Medicine. Her current research focus is on the governance of global health research; and Justice and fairness in genomics research and biobanking in Africa. She also has an interest in science communication and public engagement with Science. She has worked on a number of projects aimed at building capacity in health research ethics in the Central African Sub-region. Nchangwi has about a dozen publications in international peer-reviewed journals.

作者簡介(中文翻譯)

戈弗雷·坦瓜(Godfrey Tangwa):戈弗雷·B·坦瓜是喀麥隆雅溫得大學(University of Yaounde 1)的名譽教授,曾於2004年至2009年擔任哲學系主任。他是喀麥隆科學院(Cameroon Academy of Sciences, CAS)和非洲科學院(African Academy of Sciences, AAS)的院士,並於2005年創立了喀麥隆生物倫理倡議(Cameroon Bioethics Initiative, CAMBIN),擔任副主席,還是泛非生物倫理倡議(Pan-African Bioethics Initiative, PABIN)的執行委員會成員,以及全球新興病原體治療聯盟(Global Emerging Pathogens Treatment Consortium, GET)文化、人類學、社會和經濟(CASE)工作組的主席。他在哲學和生物倫理領域擁有豐富的教學和研究經驗。他於1977年在尼日利亞恩蘇卡大學(University of Nigeria, Nsukka)獲得學士學位,1979年在伊費大學(University of Ife,現為奧巴費米·阿沃洛沃大學)獲得碩士學位,1984年在伊巴丹大學(University of Ibadan)獲得博士學位,均在尼日利亞。他曾在世界衛生組織(WHO)擔任多個專家諮詢委員會成員,自2005年以來一直是霍夫曼·拉羅氏(Hoffmann La Roche)科學倫理諮詢小組(Scientific Ethics Advisory Group, SEAG)的成員,並且目前也是ALERRT和SARETI的諮詢委員會成員。坦瓜教授的出版紀錄顯示他有約10本書籍、35章書籍和45篇期刊文章。

阿基恩·阿巴約米(Akin Abayomi)是尼日利亞拉各斯尼日利亞醫學研究所(Nigerian Institute of Medical Research)的醫學教授。在此之前,他是南非開普敦史泰倫博斯大學(Stellenbosch University)醫學與健康科學院血液學部的首席病理學家和部門負責人。阿巴約米教授專長於內科醫學和血液學、環境健康和生物安全,他在倫敦大學聖巴多羅繆醫院皇家醫學院(Royal Medical College of St Bartholomew's Hospital)獲得了他的第一個醫學研究生學位。他獲得了英國皇家醫學和病理學院(Royal College of Medicine and Pathology)和南非醫學院(College of Medicine of South Africa)的獎學金。他曾在世界多個國家從事內科醫學和血液學的工作,並接觸到這些領域中的各種地理變異和疾病模式。阿巴約米教授的研究重點主要集中在新興疾病的概念上,如埃博拉(Ebola)、HIV和結核病(TB),以及在非洲發展實驗室和臨床能力。他是全球新興病原體治療聯盟(Global Emerging Pathogens Treatment Consortium, GET)的共同創始人和首席研究員。

塞繆爾·烏傑維(Samuel Ujewe)是一位生物倫理與健康政策的學者、研究員和分析師,專注於:健康研究倫理、醫療倫理、心理健康倫理、原住民健康倫理與政策、全球健康倫理與政策、傳染病管理的倫理、國際與跨文化生物倫理。他的研究興趣涵蓋將主要倫理理論與相關的原住民原則和價值觀相結合,以增強公正、負責任和可行的健康政策和干預措施,特別是在非洲健康系統中。他的研究專注於倫理與政策的交集,使用與原住民背景相符的道德指南針。他在英國中央蘭開夏大學(University of Central Lancashire)獲得生物倫理與健康政策的博士學位;在新西蘭奧塔哥大學(University of Otago)獲得生物倫理的健康科學碩士學位(MHealSc);以及在津巴布韋大學獲得哲學一級榮譽學士學位(First Class BA Hons)。他隨後在南非比勒陀利亞大學(University of Pretoria)和加拿大麥克馬斯特大學(McMaster University)完成了兩個博士後研究獎學金。目前,他是加拿大基因組學與社會研究所的兼任研究員,從事有關基因組創新對原住民環境的倫理影響的合作研究。

烏傑維博士是英國高等教育學院的副院士;國際倫理、生命倫理和醫療法教師論壇(International Forum of Teachers of Ethics, Bioethics and Medical Law, IFT)的成員;以及全球新興病原體治療聯盟(GET)的院士,與「文化、人類學、社會和經濟影響(CASE)工作組」合作。他還曾在塞浦路斯的中央蘭開夏大學和新西蘭的納撒尼爾中心(The Nathaniel Center)擔任訪問研究員。

辛蒂亞·門農(Nchangwi Syntia Munung)目前在南非開普敦大學(University of Cape Town, UCT)工作。她擁有生物化學碩士學位(M.Sc in Biochemistry)和醫學碩士學位(M.Sc in Medicine)。她目前的研究重點是全球健康研究的治理;以及在非洲基因組研究和生物銀行中的正義與公平。她還對科學傳播和公眾參與科學感興趣。她曾參與多個旨在提升中非子區健康研究倫理能力的項目。辛蒂亞在國際同行評審期刊上發表了約十篇論文。